Pharma's Market
SPECIAL REPORT
MOST SHARED
- Warren Buffett: Stocks Will Outperform Gold and Bonds .. and They're Safer 'By Far'
- Steelers' Antonio Brown Spends Super Bowl Week with Twitter Fan Turned BFF
- Investor Optimism At Highest In One Year: Survey
- Markets Get Greece Deal, So Where's the Big Rally?
- How to Get Your Name on the Bathroom Wall 4-EVER
- Indonesia Unexpectedly Cuts Rate to Seek Growth
- Kodak to Stop Making Cameras to Cut Costs
- Robo-Deal Is All About Lowering Mortgage Principal
- The Euro Still Has Room to Rise: Strategist
- Greeks Burn German Flags: Do They Have a Point?
- Victor Cruz ‘Understands’ Gisele's Super Bowl Frustrations
- Tamminen: The United States of India
- Unusual Volume: Taleo Jumps After Oracle's $1.9 Billion Offer
- Warren Buffett: Stocks Will Outperform Gold and Bonds .. and They're Safer 'By Far'
- So Now You Can’t Give Microsoft Away?
- Robo-Deal Is All About Lowering Mortgage Principal
- Groupon Needs More Disclosure: Analyst
- CEO to CEO: Taking a Job at a Startup vs. a Public Company
- Farr: Money, Jobs and Politics — We're Still in a State of Risk
- Markets Finally Get Greek Deal —So Where's the Rally?
- 'Mortgage Deal from Hell' Hurts Sound Borrowers: Bove
- Fidelity: 401(k) Balances Little Changed Over 2011
- Are Young American Workers a 'Lost Generation'?
- Westminster’s Most Successful Dog Breeds
- Greek Political Leaders Agree On Austerity Reforms
- Robo-Deal Is All About Lowering Mortgage Principal
- Fed Fines Banks $766 Million Over Mortgage Practices
- Spent Keurig K-Cups Filling Up US Landfills
RSS FEED
Novartis 'Cells' Its Flu Vaccine Technology
Text Size 
CNBC Correspondent
 |
AP |
For the second time in three weeks I'm at a flu vaccine manufacturing plant today.
Construction isn't finished on the Novartis [NVS
Loading...
()
] site yet, but nonetheless they're doing the formal ribbon-cutting ceremony here in Holly Springs, NC this afternoon.
Thankfully, the areas that are done aren't up and running here yet, so when I got a tour yesterday I didn't have to take my clothes off, throw on a jumpsuit and three pairs of booties like I did at Sanofi-Pasteur's [SNY
Loading...
()
] ultra-sterile plant recently. A hardhat and safety goggles were all that was required.
The innards of the plant look pretty similar to what I saw at Sanofi. The major difference is that there won't be any eggs here.
Instead, the so-called cell-based vaccine will be brewed in six 1,320 gallon fermenters. After that the purification and fill and finish process is nearly identical to the egg-based method.
And some of the contraptions here are next-generation versus the SNY equipment. For example, Sanofi has a machine with 13 cameras to take photos of filled vaccine vials and syringes from every angle looking for imperfections and impurifications. Here, Novartis has 22 cameras that officials say will snap 101,000 shots per minute. That's not a typo. 101,000 pictures every minute.
Another thing that caught my producer's eye was the bright yellow, little plastic plaque on the giant fermenters. They say that the equipment is owned by the U.S.
Government, Department of Health and Human Services.
That's because taxpayers ponied up nearly half-a-billion dollars to help pay for this place.
You hear a lot about public-private partnerships these days, but to actually see a real one is different.
Novartis will use cells taken from a dog's kidney decades ago. The company says the World Health Organization uses the same cells and for whatever reason the vaccine grows well in the canine kidney cell. Other companies use the same basic technology, but different cells ranging from human retinal to Chinese hampster ovaries (again, not a typo) to caterpillar ovaries (and again, not a typo.)
Can you imagine dissecting a caterpillar to harvest cells from its ovaries? I had a hard enough time cutting open a frog in high school biology.
Questions? Comments? and follow me on Twitter at mhuckman
Data is a real-time snapshot *Data is delayed at least 15 minutes
